12th Apr 2007 07:00
Hutchison China Meditech Limited12 April 2007 Hutchison China MediTech Limited ("Chi-Med") (AIM: HCM) Annual Report and Accounts 2006 Notice of Annual General Meeting London, Thursday, 12 April 2007: Chi-Med today announces that its Annual Reportand Accounts for the year ended 31 December 2006 together with the Notice of Annual General Meeting ("AGM") and the Proxy Form have been posted to shareholders. The documents can be accessed from the website of Chi-Med (www.chi-med.com). The AGM of Chi-Med will be held at Citigate Dewe Rogerson, 3 London WallBuildings, London, EC2M 5SY on Friday, 11 May 2007 at 2:30 p.m. Ends Enquiries Chi-Med Telephone: +852 2121 8200Christian Hogg, CEO Citigate Dewe Rogerson Telephone: +44 (0) 20 7638 9571Anthony Carlisle +44 (0) 7973 611 888Yvonne Alexander +44 (0) 7866 610 682 About Chi-Med Chi-Med is the holding company of a pharmaceutical and healthcare group basedprimarily in China and was admitted to trading on the Alternative InvestmentMarket of the London Stock Exchange in May 2006. Chi-Med is focused onresearching, developing, manufacturing, and selling pharmaceuticals, healthsupplements and other consumer health and personal care products derived fromTraditional Chinese Medicine and botanical ingredients. Chi-Med is majority owned by Hutchison Whampoa Limited, an internationalcorporation listed on the Main Board of The Stock Exchange of Hong Kong Limited. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Hutchmed